Abstract:Objective:To analyze the influence of clinicopathological features on the prognosis of anorectal malignant melanoma (AMM), and to establish a more accurate prognosis prediction model.Methods:From January 1, 2006 to December 31, 2018, at Fudan University Shanghai Cancer Center, the data of 89 patients diagnosed with AMM and underwent operation were retrospectively analyzed. The Cox proportional hazard regression model was used to analyze factors affecting the prognosis. Backward elimination was used to select variables, Nomogram prognosis prediction model was established and verified internally, and the consistency index was calculated.Results:Among 89 AMM patients, 65 (73.0%) were female, 78(87.6%) were <70 years old, and the most common tumor location was the rectum (48.3%, n=43), followed by the anal canal (31.5%, n=28) and the anorectal canal (20.2%, n=18). Thirty-eight (42.7%) patients directly received abdominal-perineal resection (APR), 37 patients (41.6%) received interferon-based immunotherapy, and 11 patients (12.4%) received both systemic chemotherapy and immunotherapy. The 3-year disease-specific survival (DSS) rate was 41.6%(37/89), and the 5-year DSS rate was 31.5%(28/89). The results of multivariate Cox analysis showed that age ≥70 years old and T2 stage were risk factors of the prognosis of AMM patients (hazard ratio ( HR)=11.29, 4.83; 95% confidence interval ( CI) 2.89 to 44.13, 1.66 to 14.11; both P<0.01), while neurovascular invasion, immunotherapy treatment, systemic chemotherapy combined with immunotherapy, APR after extensive local resection, directly APR and APR combined with inguinal lymphadenectomy were protective factors of the prognosis ( HR=0.09, 0.23, 0.10, 0.13, 0.26, 0.02; 95% CI 0.02 to 0.34, 0.10 to 0.57, 0.02 to 0.49, 0.03 to 0.52, 0.08 to 0.90, 0.00 to 0.27; all P<0.05). The Nomogram model was further established with age, gender, tumor location, T stage, distant metastasis, medication chemotherapy and surgical treatment. The results of the Nomogram model internal verification indicated that the accuracy of the model in predicting 1-year, 3-year and 5-year DSS was good, and the consistency index was 0.749, which was significantly higher than the consistency index of traditional TNM stage (0.607). Conclusions:Most AMM patients are <70 years old, and the majority of them are female. The common location of AMM is rectum, and many patients receive immunotherapy. Age ≥70 years old and T2 stage are risk factors affecting the prognosis of AMM patients. Neurovascalar invasion, immunotherapy based comprehensive treatment, APR after extensive local resection, directly APR and APR combined with inguinal lymphadenectomy are protective factors of the prognosis. Nomogram prognosis prediction model established based on the clinicopathological features and treatment of AMM patients has higher accuracy and clinical reference value than the traditional TNM stage system.

Analysis of prognosis and influencing factors of 74 cases of cutaneous melanoma

Stage-specific prognostic biomarkers in melanoma.

Significance of Clinical Factors As Prognostic Indicators for Mature T-Cell Non-Hodgkin Lymphoma Patients: A Retrospective Analysis of Chinese Cases

A Clinical Characters and Prognosis Analysis on 357 Cases with Cutaneous Malignant Melanoma in China

Surgical Treatment for Cutaneous Malignant Melanoma

Curative effect of the 1st line and the 2nd line therapies for the 232 patients with advanced mucosal melanoma and factors efecting prognosis of the patients

Survival analysis of comprehensive treatment in Chinese patients with metastatic melanoma: A retrospective analysis

Comprehensive analysis of prognostic immune‐related genes in the tumor microenvironment of cutaneous melanoma

Real-World Clinical Outcomes Of Anticancer Treatments And Prognostic Factors In Patients With Advanced Melanoma In China

Ki-67 expression in 398 cases of cutaneous melanoma and its clinical features and prognosis

Melanoma in China: A Prognostic Study of 522 Cases.

A Clinical Prognosis Model for Asian Advanced Melanoma Patients Receiving Immunotherapy.

Correlation analysis of gene and immune microenvironment for 87 melanoma cases.

Nomogram for predicting prognosis of patients with metastatic melanoma after immunotherapy: A Chinese population–based analysis

Predictors of survival in immunotherapy-based treatments in advanced melanoma: a meta-analysis

Prognostic Factors for Disease-Free Survival of Ethnic Chinese Patients with Ocularmelanoma.

Multivariate Analysis of Prognostic Factors among 706 Mucosal Melanoma Patients.

Study on the clinical features and prognostic factors of primary anorectal malignant melanoma

Primary Malignant Melanoma of the Vagina: a Retrospective Clinicopathologic Study of 44 Cases.

Efficacy of Adjuvant Programmed Cell Death 1 (PD-1) Monoclonal Antibody Immunotherapy in Chinese Patients with Resected Stage Ⅱ-Ⅲ Melanoma

Characteristics, Prognosis, and Competing Risk Nomograms of Cutaneous Malignant Melanoma: Evidence for Pigmentary Disorders